FDA Investigator Gabriel Craig
Gabriel Craig has conducted inspections on 25 sites in 1 countries as of 11 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
25
Last Inspection Date:
11 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Gabriel Craig:
Ademola O Daramola,
Alexandra B Pitkin,
Ana Djurdjevic,
Angela Shepas,
Anna J Vickrey,
April P Shaw,
Bichsa T Tran,
Binh T Nguyen,
Bonnie I Needleman,
Brian P Putz,
Brian Ravitch,
Bush,
Carey A Watson,
Carla J Lundi,
Carrie A Hughes,
Caryn M Mcnab,
Cathleen A Carr Sharpe,
Cathryn M Groehnert,
Celena Ngo,
Christina D Mello,
Christopher M Elliott,
Comyar Shoghi,
Darren S Brown,
Darrin E Davis,
David Y Hernandez,
Davis,
Debra J Fracassa,
Dejon N Harris,
Desiree C Iya,
Diana M Rand,
Doan T Nguyen, PharmD,
Donna Ltartaglino Besone,
Durell L Giles,
Dyana K Stone,
Eileen T Dupont,
Ellen N Stewart,
Francisco,
Garciam,
Geraldine M Peregrin,
Grace P Santos,
Greg K Keshishyan,
Hagstrom,
Henry E Carrillo,
Herminio C Francisco,
Irma D Padilla,
James A Barreto,
James P Stallings,
Jeff M Uriarte,
Jeffery A Johnson,
Jessica B Clark,
Jinnie Kokiatkulkij,
John A Liu,
John P Jorgensen,
John R Myung,
Joseph C Francisco,
Joseph C Yen,
Judy C Nepsa,
Julia Ventura,
Ka L Wong,
Kelvin X Sanders,
Kevin Lee,
Kevin N Tran,
Kevin T Gerrity,
Kham Phommachanh,
Kimberly M Lichter,
Lacresha Menifee,
Lanita F Kelley,
Laura A Munsterman,
Lilly O Barton,
Marcellinus D Dordunoo,
Marcus F Yambot,
Mark Gray,
Maurice M Sheehan,
Maxyne T Lam,
Michael D Garcia,
Michele R Douglas,
Natalie J Ayoub,
Natalie J Reese,
Naveen B Walker,
Nianna C Burns,
Phal K Chhun,
Phillip L Toy,
Randy L Elsberry,
Raymond W Brullo,
Richard W Tubb,
Richmond K Yip,
Robert C Hoover,
Romero,
Sara Jdent Acosta,
Sarah A Hassas,
Scott J Matsuda,
Sharon S Ho,
Sundy V Sedwick,
Tamala P Bogan,
Tamala P Magee,
Tammy Vasquez Hancock,
Tanya E Malais,
Tara L Stockton,
Tawny L Colling,
Thao T Kwan,
Thao X Tran,
Theresa Kirkham (NMI),
Timothy P Lafave,
Truong Xuan Nguyen (Andy),
Trushani T Desai,
Vanessa R Muller,
Vashti E Bocker,
William J Leonard,
Yen Tso Kuo,
Yvonne T Lacour,
Zachary A Bogorad
Gabriel Craig's Documents
Publish Date | Document Type | Title |
---|---|---|
March, 2009 | FDA 483 | P & L Development, LLC - Form 483, 2009-03-27 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more